Bath & Body Works, INC 8-K filings

Bath & Body Works announced a partial redemption of $250 million in 7.500% Senior Notes due 2029, with a redemption date set for August 19, 2026.

Bath & Body Works held its Annual Meeting of Stockholders on June 11, 2026, with key votes on director elections, auditor ratification, and executive compensation.

Bath & Body Works reported first quarter 2026 results exceeding guidance, with net sales down 3% and adjusted EPS of $0.32, while announcing CFO Eva Boratto's departure and appointing an interim CFO.

Bath & Body Works reported fourth quarter results above guidance but provided a cautious outlook for full-year 2026 with anticipated sales declines and lower adjusted earnings per share.

Bath & Body Works, Inc. announced the redemption of its 6.694% Senior Notes due 2027, effective April 10, 2026.

Bath & Body Works, Inc. announced that Michael Wu has ceased serving as Chief Legal Officer and Corporate Secretary, effective February 24, 2026.

Bath & Body Works reported third-quarter results below expectations, lowered full-year guidance, and announced a strategic transformation plan to drive sustainable long-term growth.

Bath & Body Works reported a 1.5% increase in second-quarter net sales, reaching the high end of guidance, and raised the low end of its full-year adjusted earnings per share forecast.

Bath & Body Works, Inc. announced the successful re-election of its board of directors, ratification of Ernst & Young LLP as its independent auditor, and advisory approval of executive compensation at its Annual Meeting of Stockholders on June 5, 2025.

Bath & Body Works, Inc. reported stronger-than-expected first-quarter 2025 financial results with net sales up 3% and diluted EPS up 29%, while reaffirming its full-year 2025 guidance and announcing a new CEO.

Bath & Body Works entered into an amendment and restatement of its senior secured asset-based revolving credit facility (ABL Facility) on May 22, 2025, extending the maturity and modifying terms.

Bath & Body Works names Daniel Heaf as its new CEO, effective immediately, and pre-announces strong Q1 2025 results, exceeding EPS guidance.

Bath & Body Works executive team hosted an investor tour at its Beauty Park in Columbus, Ohio, highlighting the company's agile supply chain and strategic advantages.

Bath & Body Works CEO Gina Boswell will take a temporary leave of absence starting March 20, 2025, for a scheduled surgery, with an expected return to the office after a few weeks of remote work following a four-week absence.

Bath & Body Works reaffirms its previously announced first quarter and full-year fiscal 2025 net sales and earnings per diluted share guidance during a Bank of America Consumer & Retail Conference fireside chat.

Bath & Body Works reported strong fourth-quarter results, exceeding guidance with net sales of $2.8 billion and earnings per diluted share of $2.09, and announced a new $500 million share repurchase program.

Deon Riley ceased to serve as Chief Human Resources Officer of Bath & Body Works, Inc. effective January 31, 2025, and will assist with the transition until her separation date around March 2, 2025.

Bath & Body Works has announced the redemption of all its outstanding 9.375% Senior Notes due in 2025, with a redemption date set for January 30, 2025.

Bath & Body Works reported strong third-quarter results, exceeding both net sales and earnings per share guidance, and subsequently raised its full-year outlook.

Bath & Body Works announces the departure of its President, Retail, Julie Rosen, effective immediately, while reaffirming its third quarter and full year fiscal 2024 guidance.

Bath & Body Works reported second quarter net sales in line with guidance but adjusted earnings per share exceeded expectations, while also updating its full-year outlook and increasing share repurchase plans.

Bath & Body Works amended its bylaws and held its annual meeting, electing directors and ratifying the appointment of its accounting firm.

Bath & Body Works reported first quarter 2024 results with net sales and earnings per share exceeding guidance, leading to an improved full-year outlook.

Thomas J. Kuhn resigned from the Bath & Body Works Board of Directors effective April 20, 2024, leading to a reduction in board size.

Two Bath & Body Works board members, Patricia S. Bellinger and Michael G. Morris, will not seek re-election at the 2024 Annual Meeting of Stockholders.

Bath & Body Works reported fourth quarter and full-year 2023 results that exceeded expectations, driven by strong holiday season execution and announced a new $500 million share repurchase program.